Show simple item record

dc.contributor.authorDonaghy, PC
dc.contributor.authorCiafone, J
dc.contributor.authorDurcan, R
dc.contributor.authorHamilton, CA
dc.contributor.authorBarker, S
dc.contributor.authorLloyd, J
dc.contributor.authorFirbank, M
dc.contributor.authorAllan, LM
dc.contributor.authorO'Brien, JT
dc.contributor.authorTaylor, J-P
dc.contributor.authorThomas, AJ
dc.date.accessioned2020-08-04T15:01:32Z
dc.date.issued2020-08-25
dc.description.abstractBackground Recently published diagnostic criteria for mild cognitive impairment with Lewy bodies (MCI-LB) include five neuropsychiatric supportive features (non-visual hallucinations, systematised delusions, apathy, anxiety and depression). We have previously demonstrated that the presence of two or more of these symptoms differentiates MCI-LB from MCI due to Alzheimer’s disease (MCI-AD) with a likelihood ratio >4. The aim of this study was to replicate the findings in an independent cohort. Methods Participants ≥60 years old with MCI were recruited. Each participant had a detailed clinical, cognitive and imaging assessment including FP-CIT SPECT and cardiac MIBG. The presence of neuropsychiatric supportive symptoms was determined using the neuropsychiatric inventory (NPI). Participants were classified as MCI-AD, possible MCI-LB and probable MCI-LB based on current diagnostic criteria. Participants with possible MCI-LB were excluded from further analysis. Results Probable MCI-LB (n=28) had higher NPI total and distress scores than MCI-AD (n=30). 59% of MCI-LB had two or more neuropsychiatric supportive symptoms compared with 9% of MCI-AD (likelihood ratio 6.5, p<0.001). MCI-LB participants also had significantly greater delayed recall and a lower Trails A:Trails B ratio than MCI-AD. Conclusions 5 MCI-LB is associated with significantly greater neuropsychiatric symptoms than MCI-AD. The presence of two or more neuropsychiatric supportive symptoms as defined by MCI-LB diagnostic criteria is highly specific and moderately sensitive for a diagnosis of MCI-LB. The cognitive profile of MCI-LB differs from MCI-AD, with greater executive and lesser memory impairment, but these differences are not sufficient to differentiate MCI-LB from MCI-AD.en_GB
dc.description.sponsorshipAlzheimer’s Research UKen_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationPublished online 25 August 2020
dc.identifier.doi10.1017/S003329172000290
dc.identifier.grantnumberARUK-PG3026-13en_GB
dc.identifier.urihttp://hdl.handle.net/10871/122316
dc.language.isoenen_GB
dc.publisherCambridge University Press (CUP)en_GB
dc.rights.embargoreasonUnder embargo until 25 February 2021 in compliance with publisher policyen_GB
dc.rights© The Author(s), 2020. Published by Cambridge University Press
dc.titleMild cognitive impairment with Lewy bodies: neuropsychiatric supportive symptoms and cognitive profileen_GB
dc.typeArticleen_GB
dc.date.available2020-08-04T15:01:32Z
dc.identifier.issn0033-2917
dc.descriptionThis is the author accepted manuscript. The final version is available from Cambridge University Press via the DOI in this recorden_GB
dc.identifier.journalPsychological Medicineen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2020-07-28
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2020-07-28
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-08-04T14:39:18Z
refterms.versionFCDAM
refterms.dateFOA2021-02-25T00:00:00Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record